ArticleBlood advances2019

Interleukin-2-inducible T-cell kinase inhibitors modify functional polarization of human peripheral T-cell lymphoma cells.

Sami Mamand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.